Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

PDGFA/AKT signaling is important for the growth and maintenance of certain skin fat cells.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

No treatment fully prevents hair loss from chemotherapy yet.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Lower SHBG levels may increase the risk of PCOS.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Minoxidil and finasteride effectively treat hair loss.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

ADSC-CM treatment improved hair density and thickness in women with hair loss, safely and effectively.

Skin development in mammals is controlled by key proteins and signals from underlying cells, involving stem cells for maintenance and repair.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.